News Headlines Article

House panel OKs FDA user-fee legislation
Modern Healthcare

The House Energy and Commerce Committee unanimously voted to approve the Food and Drug Administration Reform Act, which will reauthorize the drug and device user-fee programs and authorize new generic and biosimilar user-fee programs.

The Senate Health, Education, Labor and Pensions Committee voted to approve legislation that would also reauthorize and authorize previous and new user-fee programs in April.